Kundl, Austria

Roland Barth

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Sandoz Ag. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Barth. Retrieved from https://idiyas.com/inventor/roland-barth-rr2akq2l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roland Barth: Innovator in Pharmaceutical Synthesis

Introduction

Roland Barth is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of compounds used in medical treatments. His work exemplifies the intersection of innovation and practical application in the healthcare industry.

Latest Patents

Roland Barth holds a patent for a process titled "Route of synthesis for the preparation of suvorexant." This invention relates to a method for preparing a compound of formula (A). Furthermore, it discusses the respective compound (A) and its use in the preparation of an antifungal agent. This patent highlights Barth's expertise in developing new pharmaceutical processes.

Career Highlights

Barth is currently employed at Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His role at Sandoz AG allows him to contribute to the development of innovative solutions that enhance patient care and treatment options.

Collaborations

Some of his notable coworkers include Kathrin Höferl-Prantz and Frank Richter. Their collaboration within Sandoz AG fosters an environment of innovation and shared expertise, further advancing the company's mission in the pharmaceutical sector.

Conclusion

Roland Barth's contributions to pharmaceutical synthesis and his patent for the preparation of suvorexant underscore his role as an important inventor in the industry. His work continues to impact the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…